Answer to Question 1
Correct Answer: 3
Rationale 1: Cardiac arrest is not a serious side effect of delavirdine.
Rationale 2: Bone marrow suppression is not a serious side effect of delavirdine.
Rationale 3: A serious adverse effect of delavirdine (Rescriptor) is Stevens-Johnson syndrome, which appears as a rash and can be life-threatening.
Rationale 4: Seizure activity is not a serious side effect of delavirdine.
Global Rationale: A serious adverse effect of delavirdine (Rescriptor) is Stevens-Johnson syndrome, which appears as a rash and can be life-threatening. Cardiac arrest, bone marrow suppression, and seizure activity are not common adverse effects of this therapy.
Answer to Question 2
Correct Answer: 4
Rationale: CNS adverse effects are observed in at least 50 of clients when first initiating therapy, including sleep disorders, nightmares, dizziness, reduced ability to concentrate, and delusions. The CNS adverse effects usually diminish after 3 to 4 weeks of therapy.
Global Rationale: CNS adverse effects are observed in at least 50 of clients when first initiating therapy, including sleep disorders, nightmares, dizziness, reduced ability to concentrate, and delusions. The CNS adverse effects usually diminish after 3 to 4 weeks of therapy.